rheumatology
Rheumatoid arthritis

Biologic infection risk defined in Lancet meta-analysis

Evidence for the risk of serious infection with biologics has been conflicting but the Lancet has just published the most comprehensive meta-analysis of randomised trials to date. The analysis of data from 42330 patients with rheumatoid arthritis from 106 randomised trials found that compared with traditional DMARDS standard-dose biological drugs (OR 1·31) and high-dose biological ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic